ORANGE COUNTY EARNINGS
NeoTherapeutics Inc.: The Irvine drug development company posted a net loss of $2.6 million, or 47 cents a share, for the second quarter, compared with a net loss of $1.2 million, or 23 cents a share, for the second quarter of 1997. For the six months, a net loss of $5.1 million, or 93 cents a share, was reported, compared with a net loss of $2 million, or 38 cents a share, for the 1997 first half. The company said that increased expenditures for research and development contributed to the higher losses for the 1998 period.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.